0
Omeros Corporation
- 51-200 Employees
- Based in Seattle, Washington
Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets Omidria for use during cataract surgery or intraocular lens, or replacement surgery.
Omeros Corporation
Most Recent Annual Report
Omeros Corporation does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
